CERT vs EW · rev $385.1M vs P/E 47, rev $1.39B
Certara Inc (CERT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CERT currently screens at market cap $1.86B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CERT and EW stock pages for the full models.
Not investment advice.